Biogenera

It develops drugs targeting mutated DNA that causes serious diseases, with a particular focus on pediatric tumors. Its exclusive MyGenera™ platform enables the rapid identification and design of ultra-specific therapies, tailored to each patient, opening new avenues for treating previously incurable diseases.